Apersy

Apersy provide independent Life Sciences strategy consultancy services with focus on commercial strategy, reimbursement and market access. Apersy integrate the commercial point of view in the development of emerging and disruptive healthcare technologies: 🧬 innovative & precision biotech | 📱digital healthcare & AI | 🦠 microbiome medicines We understand the unique challenges of complex and personalized care and where the boundaries between device, pharmaceuticals and digital get blurry. Our work supports clients in de-risking the commercial stage, reimbursement and market access by providing strategic insights, supporting evidence generation planning, and by creating valuable assets that meet the requirements of payers. We see that care environments and payer realities are changing, so we made it our mission to help rethink product value and to support continuous commercial adaptation and optimisation. Service pillars: 💡 Product strategy, positioning & due diligence 💡 Market Access research & insight, evidence generation planning 💡 Value communication, investor decks & Market Access training